Mayne Pharma reported $72.41M in Selling and Administration Expenses for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Ansell ANN:AU $ 211.7M 34.9M
Cochlear COH:AU $ 301.9M 9.6M
CSL CSL:AU $ 748M 276.7M
Ecofibre Ltd EOF:AU 11.07M 1.44M
Healius Ltd HLS:AU $ 585.1M 79.2M
Integral Diagnostics Ltd IDX:AU 115.48M 3.63M
Nanosonics Ltd NAN:AU $ 31.95M 3.82M
Next Science Ltd NXS:AU 6.65M 1.81M
Polynovo Ltd PNV:AU 15.25M 3.06M
Probiotec Ltd PBP:AU 13.72M 2.3M
Ramsay Health Care RHC:AU $ 3.96B 9.5M
ResMed RMD:AU $ 182.4M 2.96M
Sigma Healthcare Ltd SIG:AU 159.02M 8.45M
Sonic Healthcare SHL:AU $ 2.07B 70.56M
Telix Pharmaceuticals Ltd TLX:AU 29.84M 12.69M